Literature DB >> 17332049

The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical).

Lisa Costelloe1, Killian O'Rourke, Hugh Kearney, Christopher McGuigan, Lisa Gribbin, Marguerite Duggan, Leslie Daly, Niall Tubridy, Michael Hutchinson.   

Abstract

AIM: The aims of this study were to determine the reliability, responsiveness and minimally important change score of the Multiple Sclerosis Impact Scale (MSIS)-29 physical using the Expanded Disability Status Scale (EDSS) as an anchor measure.
METHODS: 214 patients with multiple sclerosis (MS) (EDSS 0-8.5) had concurrent MSIS-29 and EDSS assessments at baseline and at up to 4 years of follow-up.
RESULTS: 116 patients had unchanged EDSS scores. Stability of the MSIS-29 physical (mean change 0.1 points) was better in the 85 patients with EDSS 0-5.0 than in the 31 patients with EDSS 5.5-8.5 in whom the MSIS-29 physical score fell by 8 points, a response shift phenomenon. A floor effect for the MSIS-29 was observed in 5% of stable patients at both time points. 98 patients experienced EDSS change with moderately strong statistically significant correlations between change scores in the EDSS and the MSIS-29 physical (r = 0.523, p<0.0001). Effect sizes for MSIS-29 physical change were moderate to large. Using receiver operating characteristic curves, the MSIS-29 change score which produced a combination of optimal sensitivity and specificity was chosen for both EDSS ranges. For EDSS range 5.5-8, a change score of 8 had a sensitivity of 87% and specificity of 67%. For EDSS 0-5.0, a change score of 7 had a sensitivity of 78% and a specificity of 51%.
CONCLUSIONS: The MSIS-29 physical performs well over time, and is suitable for use in trials; a minimal change score of 8 points in the MSIS-29 is clinically significant.

Entities:  

Mesh:

Year:  2007        PMID: 17332049      PMCID: PMC2117755          DOI: 10.1136/jnnp.2006.105759

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research.

Authors:  C E Schwartz; M A Sprangers
Journal:  Soc Sci Med       Date:  1999-06       Impact factor: 4.634

2.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Authors:  G R Cutter; M L Baier; R A Rudick; D L Cookfair; J S Fischer; J Petkau; K Syndulko; B G Weinshenker; J P Antel; C Confavreux; G W Ellison; F Lublin; A E Miller; S M Rao; S Reingold; A Thompson; E Willoughby
Journal:  Brain       Date:  1999-05       Impact factor: 13.501

3.  The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis.

Authors:  B Sharrack; R A Hughes
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

4.  One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.

Authors:  E L J Hoogervorst; M J Eikelenboom; B M J Uitdehaag; C H Polman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

5.  Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.

Authors:  E L J Hoogervorst; J N P Zwemmer; B Jelles; C H Polman; B M J Uitdehaag
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

6.  The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.

Authors:  E L J Hoogervorst; N F Kalkers; G R Cutter; B M J Uitdehaag; C H Polman
Journal:  Mult Scler       Date:  2004-02       Impact factor: 6.312

7.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

8.  The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.

Authors:  C McGuigan; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

9.  Effect sizes for interpreting changes in health status.

Authors:  L E Kazis; J J Anderson; R F Meenan
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

10.  Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.

Authors:  A Riazi; J C Hobart; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

View more
  33 in total

1.  Physical activity, self-efficacy, and health-related quality of life in persons with multiple sclerosis: analysis of associations between individual-level changes over one year.

Authors:  Robert W Motl; Edward McAuley; Daniel Wynn; Brian Sandroff; Yoojin Suh
Journal:  Qual Life Res       Date:  2012-03-09       Impact factor: 4.147

Review 2.  A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.

Authors:  Hernan Inojosa; Undine Proschmann; Katja Akgün; Tjalf Ziemssen
Journal:  J Neurol       Date:  2019-07-30       Impact factor: 4.849

3.  Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model.

Authors:  Martin Stangel; Iris Katharina Penner; Boris A Kallmann; Carsten Lukas; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2015-01       Impact factor: 6.570

4.  Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis.

Authors:  Abbey Downing; David Van Ryn; Anne Fecko; Christopher Aiken; Sean McGowan; Sarah Sawers; Thomas McInerny; Katie Moore; Louis Passariello; Helen Rogers
Journal:  Int J MS Care       Date:  2014

5.  Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.

Authors:  Y C Learmonth; E A Hubbard; E McAuley; R W Motl
Journal:  Qual Life Res       Date:  2014-02-14       Impact factor: 4.147

6.  Patients' knowledge and perception on optic neuritis management before and after an information session.

Authors:  Albert I Matti; Miriam C Keane; Helen McCarl; Pamela Klaer; Celia S Chen
Journal:  BMC Ophthalmol       Date:  2010-03-21       Impact factor: 2.209

7.  Evaluating the Effect of Functional Electrical Stimulation Used for Foot Drop on Aspects of Health-Related Quality of Life in People with Multiple Sclerosis: A Systematic Review.

Authors:  Linda Miller Renfrew; Anna C Lord; Jake Warren; Rebecca Hunter
Journal:  Int J MS Care       Date:  2019 Jul-Aug

8.  Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis.

Authors:  Fary Khan; Bhasker Amatya; Lynne Turner-Stokes
Journal:  Neurol Res Int       Date:  2011-10-17

9.  Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29.

Authors:  Melina Ramp; Fary Khan; Rose Anne Misajon; Julie F Pallant
Journal:  Health Qual Life Outcomes       Date:  2009-06-22       Impact factor: 3.186

10.  The size of the treatment effect: do patients and proxies agree?

Authors:  Femke A H van der Linden; Jolijn J Kragt; Jeremy C Hobart; Martin Klein; Alan J Thompson; Henk M van der Ploeg; Chris H Polman; Bernard M J Uitdehaag
Journal:  BMC Neurol       Date:  2009-03-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.